Tcf7-2A-EGFP-2A-CreERT
品系全名
C57BL/6JSmo-Tcf7em1(T2A-EGFP-P2A-CreERT)Smoc
目录号
NM-KI-232120
品系状态
活体
基因信息
基因名
Tcf7
品系描述
验证数据
Fig1. CreERT2 mediated recombination in Spleen of Tcf72A-EGFP-2A-CreERT2/+; Rosa26tdTomato/+ mouse.
Fig2. Detection of EGFP(green) and tdTomato(red) in various tissues of Tcf72A-EGFP-2A-CreERT2/+; Rosa26tdTomato/+ mouse.
After tamoxifen induction, tdTomato was expressed in the brain, kidney, spleen, lung, large intestine, small intestine, stomach, skin, reproductive system, thymus, and vagina. EGFP fluorescence was expressed in the brain, reproductive system, and thymus.
(41-days old, female) (For more detailed information please contact our technical advisor.)
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
